Bi-weekly very-high-dose lapatinib: an easy-to-use active option in HER-2-positive breast cancer patients with meningeal carcinomatosis
Lavaud, P., Rousseau, B., Ajgal, Z., Arrondeau, J., Huillard, O., Alexandre, J., Hulin, A., Goldwasser, F.
Published in Breast cancer research and treatment (01.05.2016)
Published in Breast cancer research and treatment (01.05.2016)
Get full text
Journal Article
Combination of radiotherapy and double blockade HER2 with pertuzumab and trastuzumab for HER2-positive metastatic or locally recurrent unresectable and/or metastatic breast cancer: Assessment of early toxicity
Ajgal, Z., de Percin, S., Diéras, V., Pierga, J.Y., Campana, F., Fourquet, A., Kirova, Y.M.
Published in Cancer radiothérapie (01.04.2017)
Published in Cancer radiothérapie (01.04.2017)
Get full text
Journal Article
2406P Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic squamous cell carcinoma of the penis: Subgroup analysis of the PEVOsq basket trial
Coquan, E., Gomez-Roca, C.A., Lambert, A., You, B., Vansteene, D., Bigot, F., Cousin, S., Ajgal, Z. Castel, Jeannot, E., Guerini Rocco, E., Frige, G., Mazzarella, L., Francisco, M., Servant, N., Halladjian, M., Kamal, M., Legrand, F., Jimenez, M., Cabarrou, B., Le Tourneau, C.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1742P Phase II study of rucaparib and atezolizumab (ARIANES): Results in patients (pts) with platinum-sensitive metastatic urothelial cancer (mUC) and metastatic castration-resistant prostate cancer (mCRPC)
Martin Romano, P., Roubaud, G., Lavaud, P., Cabart, M., Pages, A., Vasseur, D., Colomba, E., Cousin, S., Toulmonde, M., Grellety, T., Castel Ajgal, Z., Chabanon, R., Parpaleix, A., Buzzatti, G., Fizazi, K., Gomez-Roca, C.A., Italiano, A., Loriot, Y., Postel-Vinay, S.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
MON-P116: PI3KINASE-AKT-Mtor Pathway and Glutamine Metabolism in Ovarian Cancer
Ajgal, Z., Le Plenier, S., Ricci, S., Neveu, N., Alexandre, J., Goldwasser, F., De Bandt, J.-P., Cynober, L., Blanc, M.-C.
Published in Clinical nutrition (Edinburgh, Scotland) (01.09.2017)
Published in Clinical nutrition (Edinburgh, Scotland) (01.09.2017)
Get full text
Journal Article
Congrès Targeted Anticancer Therapies — TAT 2015
Ajgal, Z., Bellesoeur, A., Baylot, C., Bigenwald, C., Brunot, A., Carton, E., De Guillebon, E., De Nonneville, A., Martin-Babau, J., Flippot, R., Gougis, P., Mahjoubi, L., Marques, N., Larrouquère, L., Pons, E., Verlingue, L., Viala, M., Vicier, C., Vinceneux, A., Vozy, A., Lavaud, P., Ferté, C.
Published in Oncologie (Paris, France) (01.07.2015)
Published in Oncologie (Paris, France) (01.07.2015)
Get full text
Journal Article